WASHINGTON (dpa-AFX) - Becton, Dickinson and Co. or BD (BDX) on Thursday provided an update on two voluntary recalls related to certain Alaris Pump Modules Model 8100 manufactured between April 2011 ...
The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...
To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...
A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.
FRANKLIN LAKES, N.J., July 18, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls ...
FDA recently announced that a recall of the CareFusion Alaris syringe infusion pump has given FDA's most serious recall classification. The company has had nine Class 1 recalls of its Alaris-branded ...
CareFusion is recalling 7,418 units of its Alaris Syringe infusion pump, a corrective action that the FDA just deemed Class 1. This marks CareFusion's ninth Class 1 recall of an Alaris device since ...
FRANKLIN LAKES, N.J., Sept. 21, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on previously announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results